Top News
FEATURED
BIA-ALCL Linked to Textured Surface
Europe halts sales of textured breast implants as more studies demonstrate a link between this type of implant and the development of a rare lymphoma.
Fact Sheet: Cancer During Pregnancy
Most studies suggest that treatment with chemotherapy is generally acceptable during the second and third trimesters.
Is RWE a Complement to RCTs?
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives.
Predictions in Medicine 2019: What's Ahead
A new partner in the fight to cure cancer. A once-unlikely source for combatting clinician burnout. These are some of the advances we and other experts predict will affect oncologists and their patients in 2019 and beyond. Take a look inside our crystal ball.
Ask the Experts: NSCLC
Cancer Therapy Advisor asked 2 experts to weigh in on recommended treatment modalities for patients with non-small cell lung cancer.
Ask the Experts: STS Clinical Insights
Cancer Therapy Advisor asked 2 experts to weigh in on the latest clinical insights into soft tissue sarcoma.
Ask the Experts: Waldenström Macroglobulinemia
Cancer Therapy Advisor asked 3 experts to weigh in on recommended treatment modalities for patients with Waldenström macroglobulinemia.
Looking for a Job?
Access our job board to view over 1,200 job openings throughout the US.
Treatment Regimens
A full listing of cancer treatment and drug information is available to access.
Latest Features
Evidence Grows Linking BIA-ALCL to Textured Surface of Some Breast Implants
Europe halts sales of textured breast implants as more studies demonstrate a link between this type of implant and the development of a rare lymphoma.
Could Cytostatic Drugs Unleash Antitumor Immunity in Lung Cancer?
The combination of trametinib and palbociclib induced attack by NK cells — but not killing — of xenograft lung tumors in lab animals.
Malignant Pleural Effusion Interventions: What Matters Most to the Patient?
Patients with malignant pleural effusion may care more about relieving symptoms such as dyspnea as opposed to achieving pleurodesis.
Is Real-World Evidence a Complement to Randomized Clinical Trials?
Use of real-world data has the potential to accelerate drug and device approvals in rare diseases and advance precision medicine initiatives.
Renal Cell Carcinoma: Treatment Paradigms in Octogenarians
Significantly fewer patients had radical nephrectomy in 2004 compared with 2015.
Editorial Advisory Board
E. David Crawford, MD
Jeffrey M. Farma, MD
Digital Issue
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Is Real-World Evidence a Complement to Randomized Clinical Trials?
- Cancer During Pregnancy
- Renal Cell Carcinoma: Treatment Paradigms in Octogenarians
- MSI-H/dMMR Is Clinically Meaningful, Despite Being Uncommon in Prostate Cancer
- Evidence Grows Linking BIA-ALCL to Textured Surface of Some Breast Implants
- Lifestyle Factors Accelerated Age-Related Remodeling of Esophageal Tissue
- Primary End Point Not Met in Trial Testing Nivolumab Monotherapy for DLBCL
- Could Cytostatic Drugs Unleash Antitumor Immunity in Lung Cancer?
- Chemoimmunotherapy Regimen Confers Benefit in Double Expressor DLBCL